persistent atrial fibrillation
Conditions
Interventions
Experimental group:Radiofrequency ablation
Sponsors
The Second Affiliated Hospital of Nanchang University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Age 18 to 80 years old; 2. Patients with symptomatic persistent atrial fibrillation; 3. Those who are ineffective or intolerable after at least one class I or class III AAD treatment, or those who do not accept class I or class III AAD treatment; 4. Willing to participate in the trial and accept the follow-up required by the protocol and sign the written informed consent.
Exclusion criteria
Exclusion criteria: 1. Retreatment patients after ablation of tachy atrial arrhythmia; 2. combined with atrial tachycardia or atypical atrial flutter; 3. Left atrial diameter>55mm; 4. Left ventricular ejection fraction <35%; 5. Left atrial thrombus; 6. After cardiac surgery; 7. After valve replacement; 8. After permanent pacemaker implantation; 9. Hypertrophic cardiomyopathy; 10. Rheumatic heart disease; 11. Hemorrhagic stroke within 6 months; 12. Transient ischemic attack or ischemic stroke within 1 month; 13. History of malignant tumor; 14. Mental disorder or a history of mental illness and unable to cooperate independently; 15. Breast feeding, pregnancy, and women who plan or may become pregnant; 16. Life expectancy < 12 months; 17. Participating in other interventional clinical trials; 18. Judged by the investigator to be unsuitable for inclusion in this trial.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 12-month success rate;Incidence of major adverse events; | — |
Secondary
| Measure | Time frame |
|---|---|
| Immediate success rate; | — |
Countries
China
Contacts
Public ContactXiaoshu Cheng
The Second Affiliated Hospital of Nanchang University
Outcome results
None listed